this study reports on the occurence of JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib.
JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib / Pieri, L., Pancrazzi, A., Pacilli, A., Rabuzzi, C., Rotunno, G., Fanelli, T., Guglielmelli, P., Fjerza, R., Paoli, C., Verstovsek, S., Vannucchi, A.M.. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 125:(2015), pp. 3352-3353. [10.1182/blood-2015-01-624536]
JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib
PIERI, LISA;PANCRAZZI, ALESSANDRO;PACILLI, ANNALISA;ROTUNNO, GIADA;FANELLI, TIZIANA;GUGLIELMELLI, PAOLA;FJERZA, RAJMONDA;PAOLI, CHIARA;VANNUCCHI, ALESSANDRO MARIA
2015
Abstract
this study reports on the occurence of JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Pieri_Blood_2015.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
499.43 kB
Formato
Adobe PDF
|
499.43 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
